Free

Event Information

Share this event

Date and Time

Location

Location

The Lord Selborne Suite

Chilworth Manor

Chilworth

Southampton

SO16 7PT

United Kingdom

View Map

Event description

Description

The NIHR Clinical Research Network (CRN) Wessex invites clinicians, surgeons and research nurses to celebrate breast surgical and oncology research at our event.

Chaired by Professor Ramsey Cutress, Consultant Surgeon at University Hospital Southampton NHS Foundation Trust.

Presentations will be followed by dinner and networking. The dinner will be buffet style. Please specify any dietary requirements when booking. The full agenda and speaker bios are included below. For all event enquiries, please contact studysupport1and3.crnwessex@nihr.ac.uk

Agenda

18.30- Registration, Tea & Coffee which will be served in the Herb Garden Room

18.50- Event commences in the Lord Selborne Suite (directly opposite the Herb Garden room) with a welcome and introduction from Professor Ramsey Cutress.

19.00- Mr Stuart McIntosh – Current Clinical Trials in Breast Cancer

19.40- Dr Ellen Copson – Breast Research Collaboration Across the Network

20.00- Lesley Turner – Cancer patients access to and experience of cancer research

20.15- Panel discussion and Partnership working

20.45- Dinner


Speaker bios

Mr Stuart McIntosh

Stuart McIntosh is a specialist breast surgeon at Belfast City Hospital and a Clinical Senior Lecturer in Surgical Oncology at Queen’s University in Belfast. He graduated from Edinburgh University in 1993, and completed his general surgical training in the North-East of Scotland, moving to Belfast in 2009, and to an academic position in 2015.

He is an experienced breast cancer clinical trialist, having contributed to a large number of trials in early breast cancer, with a particular emphasis on neoadjuvant, peri-surgical and treatment de-escalation studies. He is the Chief Investigator for the UK SMALL trial, a national multicentre study comparing standard surgery with vacuum-assisted excision for the treatment of biologically-favourable screen-detected breast cancers.

As a member of both the UK National Cancer Research Institute Breast Clinical Studies Group and the NCRI Strategic Advisory Group he has an excellent overview of the portfolio of clinical and translational breast cancer research in the UK. In his role as the Royal College of Surgeons Breast Surgical Specialty Lead he is responsible for supporting the development and delivery of breast cancer trials nationally, with a specific emphasis on surgical studies.

Active in translational laboratory research, he has been developing a breast cancer research programme within Queen’s University in Belfast. His interests in this area include breast cancer risk, genetic predisposition and mechanisms of tumourigenesis. In collaboration with the DNA damage repair and immune-oncology groups within QUB, he has been working on understanding response to neoadjuvant chemotherapy in breast cancer, and the interaction between DNA damage and immune response in cancer.

He has been heavily involved in the development of breast cancer tissue banking in Northern Ireland, and has acted as Cancer Lead for the UK 100 000 Genomes project in NI, which has sought to build genomic medicine capacity for the NI cancer patients. He also acts as Clinical Director for the Northern Ireland Cancer Trials Network, responsible for overseeing the delivery of cancer clinical research across the five cancer hospitals in Northern Ireland.

Dr Ellen Copson

Dr Copson is Associate Professor and honorary consultant in Medical Oncology at the University of Southampton, where she specialises in treating breast cancer. Following a PhD studying the molecular genetics of the BRCA1 gene, Dr Copson has a particular interest in the genomic and modifiable host factors which influence the outcome of early breast cancer.

She is a lead researcher on the POSH study, a large national cohort study of young breast cancer patients and is involved with a number of research studies investigating various aspects of breast cancer genomics and body composition/ nutrition in cancer. She is also principle investigator for many clinical trials in early and advanced breast cancer.

Dr Copson is Cancer lead of the Wessex Genomic Medical Centre, and chair of the National Oncogenetics Training Working Party. She was a member of the NIHR Breast Cancer Clinical Studies Group for 6 years and is a member of the RCP Speciality Certificate Examination Board. She has has recently led the development of a new national Breast Cancer Trainees Research Collaborative Group.

Lesley Turner

Lesley Turner is a Patient Advocate and a breast cancer patient who was diagnosed with invasive breast cancer in 2005 and underwent a radical mastectomy with axillary clearance.

She has been a member of the National Cancer Research Institute’s Supportive and Palliative Care Clinical Studies Group, and sits as the Co-Chair of the NCRI Breast Clinical Studies Sub-Group working on symptom management issues. She is also an active member of the NCRI Consumer Forum, and Independent Cancer Patients’ Voice.

She is a Member of Breast Cancer Now’s Tissue Bank Advisory Council, and a Member of the Breast Cancer Now’s Catalyst Grant Committee which has funded numerous studies to date worth approximately £10 million.

She is a co-applicant on a number of trials including the YodaBRA trial which designed and tested an online interactive genetic testing decision aid for young women diagnosed with early stage breast cancer; and the MENOS4 trial – a RCT testing the effectiveness of nurse led group CBT for hot flushes and night sweats in women with breast cancer.

Share with friends

Date and Time

Location

The Lord Selborne Suite

Chilworth Manor

Chilworth

Southampton

SO16 7PT

United Kingdom

View Map

Save This Event

Event Saved